NCT02531711

Brief Summary

The goal of this proposed research is to assess the preliminary efficacy of dietary interventions that change dietary fats in improving clinical outcomes related to lumbar radicular pain. After a two-week baseline, consented participants are randomized to one of two diets. Key foods consistent with the diet are provided for 12 weeks along with extensive dietary counseling and support from the study-provided materials. Participants are encouraged to follow the assigned diet for another 6 weeks without provision of food. Participants complete questionnaires at baseline, randomization, and after 6 weeks, 12 weeks, and 18 weeks on the diet. They provide blood samples at randomization (2 weeks) and after 12 and 18 weeks on the diet.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Sep 2015

Longer than P75 for not_applicable pain

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 8, 2015

Completed
3 months until next milestone

First Posted

Study publicly available on registry

August 24, 2015

Completed
8 days until next milestone

Study Start

First participant enrolled

September 1, 2015

Completed
4.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2019

Completed
Last Updated

October 8, 2020

Status Verified

October 1, 2020

Enrollment Period

4.3 years

First QC Date

June 8, 2015

Last Update Submit

October 7, 2020

Conditions

Keywords

Lumbosacralradicular

Outcome Measures

Primary Outcomes (2)

  • Oswestry Disability Index--Primary clinical outcome

    Measure of pain-specific quality of life

    12 weeks

  • 17-Hydroxy Docosahexaenoic acid (DHA)--Primary biochemical outcome

    Metabolite related to dietary fatty acid intakes implicated in pain reductions

    12 weeks

Secondary Outcomes (7)

  • Pain intensity

    12 weeks

  • Physical activity

    12 weeks

  • Sleep efficiency

    12 weeks

  • Sleep quantity

    12 weeks

  • Self-reported health

    12 weeks

  • +2 more secondary outcomes

Study Arms (2)

Diet A

EXPERIMENTAL

Dietary intervention: Dietary fats are adjusted. Key study foods and oils are provided for 12 weeks. Participants learn which foods to eat and which to avoid.

Other: Diet A

Diet B

ACTIVE COMPARATOR

Dietary intervention: This diet also adjusts dietary fats, and provides key study foods and oils for 12 weeks.

Other: Diet B

Interventions

Diet AOTHER

Experimental analgesic dietary intervention

Diet A
Diet BOTHER

Healthy comparator diet

Diet B

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • MRI-verified lumbosacral radiculopathy associated with herniated disc, spinal stenosis, or post-surgical fibrosis
  • Pain reaching to the knee for at least 12 weeks
  • Willing to complete daily diary for 20 weeks, as evidenced by completion of ≥12 of the first 14 days
  • Possessing a mobile device (smart phone, tablet, laptop) capable of accessing the application and website
  • Able to attend dietitian counseling sessions in Chapel Hill, NC
  • Under care of a physician for LR
  • Able to read and communicate in English

You may not qualify if:

  • Psychosis or severe depression, anxiety, substance abuse disorder
  • History of specific food allergies that would prevent adherence to study diet
  • Aversion to eating fish
  • Currently taking fish oil or other supplements that contain fatty acids under investigation
  • Pregnancy or anticipated pregnancy
  • Active treatment for a major medical illness, such as malignancy, autoimmune, immune deficiency disorder
  • History of vasculitis, intracranial mass, clotting disorder (including medication-induced, e.g., warfarin)
  • Cognitive dysfunction preventing informed consent
  • Pending personal injury litigation, including worker's compensation
  • Chronic long-term disability related to lumbosacral injury/symptoms

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina at Chapel Hill

Chapel Hill, North Carolina, 27599-7200, United States

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Kevin Carneiro, DO

    Department of Physical Medicine and Rehabilitation, University of North Carolina at Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 8, 2015

First Posted

August 24, 2015

Study Start

September 1, 2015

Primary Completion

December 30, 2019

Study Completion

December 30, 2019

Last Updated

October 8, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will share

Deidentified data will be shared with investigators at NIH.

Locations